Search
for
Sort by
Research 691–720 of 1000+
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- What causes hidradenitis suppurativa ?—15 years after
- Management of Hair Loss
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Quality of Life in Alopecia Areata: A Study of 60 Cases
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Differential diagnosis of hair loss in children. Differentialdiagnose des Haarausfalls bei Kindern
- Systematic Review of Psychological Interventions for Quality of Life, Mental Health, and Hair Growth in Alopecia Areata and Scarring Alopecia
- Platelet-Rich Plasma for the Aesthetic Surgeon
- Treating Alopecia Areata: Current Practices Versus New Directions
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- A “hair‐raising” history of alopecia areata
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Mesenchymal Stem Cells and Stromal Vascular Fraction for Hair Loss
- Serum level of vitamin D in patients with alopecia areata
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Alopecia areata following COVID-19 vaccine: a systematic review
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Approach to Patients with Suspected Rheumatic Disease
- Skin Diseases in Horses
- Differential impact of environmental factors on systemic and localized autoimmunity